Development of a Prenatal Test for Fetal Aneuploidy Detection

Completed

Conditions studied: Fetal Complications

In brief

This is an observational study to develop and evaluate a blood based prenatal blood test. Pregnant women confirmed to be carrying a fetus with a chromosomal abnormality will be eligible. Subjects will be asked to provide a blood sample and a limited amount of clinical data that will be recorded on a case report form. All samples and clinical data will be stripped of subject identifiers prior to submission to Ariosa.

Key facts

Study ID

NCT01451671

Run by

Cindy Cisneros

People needed

1500

Starts

2010-11-01

Expected to finish

2019-11-01

Last updated by the study team

2020-04-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subject has singleton pregnancy
• Subject is confirmed via invasive testing to be carrying a fetus with a chromosomal abnormality
• Subject is able to provide informed consent
• Subject is ≥ 18 years of age

You may not qualify if…

• Subject is pregnant with more than one fetus
• Subject (mother) has a known aneuploidy

Where it is running

• University of California San Diego — San Diego, California, United States
• Norton Healthcare — Louisville, Kentucky, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.